These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35913111)

  • 1. Safety of direct oral anticoagulants in patients with liver disease: a systematic review and meta-analysis.
    Zhao Y; Zhu L; Yang Y; Gao H; Zhang R
    Acta Clin Belg; 2023 Jun; 78(3):234-244. PubMed ID: 35913111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
    Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of gastrointestinal hemorrhage with non-vitamin K antagonist oral anticoagulants: A network meta-analysis.
    Oh HJ; Ryu KH; Park BJ; Yoon BH
    Medicine (Baltimore); 2021 Mar; 100(11):e25216. PubMed ID: 33726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease: A Meta-Analysis and Systematic Review.
    Fu Y; Zhu W; Zhou Y; Chen H; Yan L; He W
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):139-147. PubMed ID: 31485852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct oral anticoagulants and advanced liver disease: A systematic review and meta-analysis.
    Menichelli D; Ronca V; Di Rocco A; Pignatelli P; Marco Podda G;
    Eur J Clin Invest; 2021 Mar; 51(3):e13397. PubMed ID: 32895926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants Versus Warfarin for Treatment of Thrombosis or Atrial Fibrillation in Patients With Cirrhosis: A Retrospective Cohort Study.
    Coons EM; Staubes BA; Casey AL; Elagizi-Youssef SA; Mohammed AE; Sharma N; Kline ER
    Ann Pharmacother; 2022 May; 56(5):533-540. PubMed ID: 34470525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants for venous thromboembolism in cancer patients: a systematic review and network meta-analysis.
    Wu S; Lv M; Chen J; Jiang S; Chen M; Fang Z; Zeng Z; Qian J; Xu W; Guan C; Zhang J
    Support Care Cancer; 2022 Dec; 30(12):10407-10420. PubMed ID: 36318341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Bleeding in Liver Cirrhosis Receiving Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.
    Li Z; Xu W; Wang L; Chai L; Ageno W; Romeiro FG; Li H; Qi X
    Thromb Haemost; 2023 Nov; 123(11):1072-1088. PubMed ID: 37336474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
    Hu W; Cai H; Zhang J
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Oral Anticoagulants vs. Vitamin K Antagonists in Atrial Fibrillation Patients at Risk of Falling: A Meta-Analysis.
    Gao X; Huang D; Hu Y; Chen Y; Zhang H; Liu F; Luo J
    Front Cardiovasc Med; 2022; 9():833329. PubMed ID: 35615562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Liver Disease: a Meta-Analysis and Systematic Review.
    Huang ZC; Li CQ; Liu XY; Cao ZC; Jia HY; Dong Y; Liu TL; Sun JJ
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1205-1215. PubMed ID: 32880804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    López-López JA; Sterne JAC; Thom HHZ; Higgins JPT; Hingorani AD; Okoli GN; Davies PA; Bodalia PN; Bryden PA; Welton NJ; Hollingworth W; Caldwell DM; Savović J; Dias S; Salisbury C; Eaton D; Stephens-Boal A; Sofat R
    BMJ; 2017 Nov; 359():j5058. PubMed ID: 29183961
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.
    Xu W; Lv M; Wu S; Jiang S; Zeng Z; Fang Z; Qian J; Chen M; Chen J; Zhang J
    Cardiovasc Drugs Ther; 2023 Apr; 37(2):363-377. PubMed ID: 34436708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation Across BMI Categories: A Systematic Review and Meta-Analysis.
    Zhou Y; Ma J; Zhu W
    Am J Cardiovasc Drugs; 2020 Feb; 20(1):51-60. PubMed ID: 31342343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Clinical Outcomes of Edoxaban in Adults With Nonvalvular Atrial Fibrillation.
    Aronow WS; Shamliyan TA
    Am J Ther; 2020; 27(3):e270-e285. PubMed ID: 30277905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the Safety and Efficacy of Direct Oral Anticoagulants and Warfarin in Atrial Fibrillation or Venous Thromboembolism in Patients with Renal Impairment: Systematic Review, Meta-Analysis and Network Meta-Analysis.
    Wang Z; Xiang Q; Hu K; Zhang X; Xie Q; Liu Z; Cui Y
    Am J Cardiovasc Drugs; 2021 Nov; 21(6):643-657. PubMed ID: 33817758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis.
    Boonyawat K; Caron F; Li A; Chai-Adisaksopha C; Lim W; Iorio A; Lopes RD; Garcia D; Crowther MA
    J Thromb Haemost; 2017 Jul; 15(7):1322-1333. PubMed ID: 28407368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
    Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
    Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.